Thank you for your question. It is not unreasonable to perform a biopsy for a
PSAPsa
Psa blood test level of 3.2 at 48 years old. Established risk
factorsFactor ix complex for prostate cancer include african american race and
firstFirst progesterone mc10
First progesterone mc5
First-progesterone vgs 100
First-progesterone vgs 200
First-progesterone vgs 25
First-progesterone vgs 400
First-progesterone vgs 50
First-testosterone
First-testosterone mc degree relative with the disease. Furthermore, your urologist may be suggesting a biopsy based on DRE (
digitalDigital rectal exam rectalAnorectal fistulas
Colon cancer
Colorectal polyps
Digital rectal exam
Hemorrhoids
Imperforate anus
Imperforate anus repair
Inflatable artificial sphincter
Proctitis
Rectal biopsy
Rectal cancer, x-ray examination) findings.
Sincerely,
Ashutosh (Ash) Tewari, MD
http://www.cornellroboticprostate.org
This forum is for information only. The contents, such as graphics, images, text, quoted information and all other materials ("Content") are provided for reference only, do not claim to be complete or exhaustive or to be applicable to any particular individual's medical condition. Users should always consult with a qualified and licensed physician or other medical care provider. Users are warned to follow the advice of their physicians without delay regardless of anything read in this forum. The Weill Cornell Prostate Cancer Institute assumes no duty to correct or update the Content nor to resolve or clarify any inconsistent information which may be a part of the Content. Reliance on any Content is solely at the User's risk. This forum may contain health or medically related materials considered sexually explicit. Users are warned that if they may be offended by such Content, an alternate source of information should be found. Publication of information or reference in forum to specific sources such as specific products, procedures, physicians, treatments, or diagnoses are for information only and are not endorsements of the Weill Cornell Prostate Cancer Institute.